Key facts
- Manuals
- 1
- Languages
- ZH
- Last added
- 2026-09-28
Featured Pfizer manuals
Pfizer Tolterodine L‑Tartrate Sustained Release Capsules Product Leaflet
This leaflet provides detailed information on Tolterodine L‑Tartrate Sustained Release Capsules, a medication used to treat overactive bladder symptoms such as urgency, frequency and urge incontinence. It includes the drug’s generic and English names, chemical composition, appearance, therapeutic indications, and available strengths (2 mg and 4 mg).
The document also covers recommended dosing, adjustments for special populations (renal or hepatic impairment, concomitant CYP inhibitors), contraindications, warnings, adverse reactions, drug interactions, overdose handling, and storage conditions. Contact information for the manufacturer and packaging company is provided at the end. This manual is written in Chinese.
Covers: 药品名称 · 成分 · 性状 · 适应症 · 规格 · 用法用量
Latest Pfizer manuals
Pfizer Tolterodine L‑Tartrate Sustained Release Capsules Product Leaflet
Product Leaflet 20 pages · 294 KB · ZHInstructions for Tolterodine L‑Tartrate SR capsules, including dosage, indications, side effects and storage.
Questions answered in Pfizer manuals
What are the most common adverse reactions?
The most frequently reported side effects are dry mouth, headache, constipation and abdominal pain.
From: Pfizer Tolterodine L‑Tartrate Sustained Release Capsules Product Leaflet
Can Tolterodine SR be used in patients with severe liver impairment?
No, it is not recommended for patients with severe liver impairment (Child‑Pugh class C).
From: Pfizer Tolterodine L‑Tartrate Sustained Release Capsules Product Leaflet